From complexity to clarity in cell and gene therapy
Breakthrough CGT therapies are coming thick and fast, now pharma must work on multiple fronts to educate non-specialist stakeholders about their exciting possibilities
Close log in window
View the results of a survey of over 1000 pharma executives on the impact COVID-19 has had and will have on their operations
Pharma should team up with HCPs, regulators and health ministries to create harmonised, interoperable health records and so drive cheaper, f...
Regeneron shares its latest progress on therapies for the pandemic at eyeforpharma Philadelphia virtual
Pharma is rapidly adapting its approach to trials in the face of the pandemic and there is great opportunity for far reaching improvements o...
